Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertaconazole vs Clotrimazole for Tinea Pedis
NCT06869681Phase 4Not yet recruiting
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Mar 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sertaconazole nitrate in tinea pedis (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Frequency of Efficacy at 4 weeks. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
sertaconazole nitrate
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT06869681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06869681.